1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Agonist
1.2.3 Allosteric Modulator
1.2.4 Kinase Inhibitor
1.2.5 Monoclonal Antibody
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Perspective (2017-2028)
2.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Growth Trends by Region
2.2.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Dynamics
2.3.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Industry Trends
2.3.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers
2.3.3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Challenges
2.3.4 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Revenue
3.1.1 Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Revenue (2017-2022)
3.1.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue
3.4 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Concentration Ratio
3.4.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2021
3.5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players Head office and Area Served
3.6 Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Solution and Service
3.7 Date of Enter into Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Breakdown Data by Type
4.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Type (2023-2028)
5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Breakdown Data by Application
5.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2017-2028)
6.2 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type
6.2.1 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022)
6.2.2 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028)
6.2.3 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2017-2028)
6.3 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application
6.3.1 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022)
6.3.2 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028)
6.3.3 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2017-2028)
6.4 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country
6.4.1 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022)
6.4.2 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2017-2028)
7.2 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type
7.2.1 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2017-2028)
7.3 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application
7.3.1 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2017-2028)
7.4 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country
7.4.1 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application
8.3.1 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2017-2028)
9.2 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type
9.2.1 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2017-2028)
9.3 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application
9.3.1 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2017-2028)
9.4 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country
9.4.1 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application
10.3.1 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.1.4 Roche Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Regeneron Pharmaceuticals
11.2.1 Regeneron Pharmaceuticals Company Details
11.2.2 Regeneron Pharmaceuticals Business Overview
11.2.3 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.2.4 Regeneron Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.2.5 Regeneron Pharmaceuticals Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.3.4 Bayer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Santen Oy
11.4.1 Santen Oy Company Details
11.4.2 Santen Oy Business Overview
11.4.3 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.4.4 Santen Oy Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.4.5 Santen Oy Recent Developments
11.5 Kanghong Pharmaceuticals
11.5.1 Kanghong Pharmaceuticals Company Details
11.5.2 Kanghong Pharmaceuticals Business Overview
11.5.3 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.5.4 Kanghong Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.5.5 Kanghong Pharmaceuticals Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.6.4 Novartis Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.7.4 Eli Lilly and Company Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Developments
11.8 TRACON Pharmaceuticals
11.8.1 TRACON Pharmaceuticals Company Details
11.8.2 TRACON Pharmaceuticals Business Overview
11.8.3 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.8.4 TRACON Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.8.5 TRACON Pharmaceuticals Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.9.4 Pfizer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.9.5 Pfizer Recent Developments
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.10.4 GSK Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.10.5 GSK Recent Developments
11.11 BIOCAD
11.11.1 BIOCAD Company Details
11.11.2 BIOCAD Business Overview
11.11.3 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
11.11.4 BIOCAD Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
11.11.5 BIOCAD Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Agonist
Table 3. Key Players of Allosteric Modulator
Table 4. Key Players of Kinase Inhibitor
Table 5. Key Players of Monoclonal Antibody
Table 6. Key Players of Others
Table 7. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Region (2017-2022)
Table 11. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Region (2023-2028)
Table 13. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Trends
Table 14. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers
Table 15. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Challenges
Table 16. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Restraints
Table 17. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Players (2017-2022)
Table 19. Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs as of 2021)
Table 20. Ranking of Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Solution and Service
Table 24. Date of Enter into Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Application (2017-2022)
Table 32. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Application (2023-2028)
Table 34. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 67. Roche Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 68. Roche Recent Developments
Table 69. Regeneron Pharmaceuticals Company Details
Table 70. Regeneron Pharmaceuticals Business Overview
Table 71. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 72. Regeneron Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 73. Regeneron Pharmaceuticals Recent Developments
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 77. Bayer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 78. Bayer Recent Developments
Table 79. Santen Oy Company Details
Table 80. Santen Oy Business Overview
Table 81. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 82. Santen Oy Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 83. Santen Oy Recent Developments
Table 84. Kanghong Pharmaceuticals Company Details
Table 85. Kanghong Pharmaceuticals Business Overview
Table 86. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 87. Kanghong Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 88. Kanghong Pharmaceuticals Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 92. Novartis Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 97. Eli Lilly and Company Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 98. Eli Lilly and Company Recent Developments
Table 99. TRACON Pharmaceuticals Company Details
Table 100. TRACON Pharmaceuticals Business Overview
Table 101. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 102. TRACON Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 103. TRACON Pharmaceuticals Recent Developments
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 107. Pfizer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 108. Pfizer Recent Developments
Table 109. GSK Company Details
Table 110. GSK Business Overview
Table 111. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 112. GSK Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 113. GSK Recent Developments
Table 114. BIOCAD Company Details
Table 115. BIOCAD Business Overview
Table 116. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product
Table 117. BIOCAD Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022) & (US$ Million)
Table 118. BIOCAD Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Agonist Features
Figure 3. Allosteric Modulator Features
Figure 4. Kinase Inhibitor Features
Figure 5. Monoclonal Antibody Features
Figure 6. Others Features
Figure 7. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Report Years Considered
Figure 12. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Players in 2021
Figure 16. Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2021
Figure 18. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Type (2017-2028)
Figure 20. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Application (2017-2028)
Figure 21. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Country (2017-2028)
Figure 22. United States Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Type (2017-2028)
Figure 26. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Application (2017-2028)
Figure 27. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Country (2017-2028)
Figure 28. Germany Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Region (2017-2028)
Figure 38. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Country (2017-2028)
Figure 48. Mexico Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Country (2017-2028)
Figure 54. Turkey Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Roche Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 59. Bayer Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 60. Santen Oy Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 61. Kanghong Pharmaceuticals Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 64. TRACON Pharmaceuticals Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 66. GSK Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 67. BIOCAD Revenue Growth Rate in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
